This publication does not argue against an ambitious agenda for change. On the contrary, Australia's decision-making on health technologies is crying out for change. The argument is that it cannot be delivered within the constraints of an institution that has never demonstrated any ability to reform itself, engage in self-reflection, or take responsibility for the issues afflicting access in Australia.
Be clear-eyed about whatever trade-offs the institution demands you accept
September 10, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The industry walked out on Britain, and what it cost to win them back
October 22, 2026 - - Latest News -
BioNTech opens mRNA plant, putting Melbourne's north on the biotech map
October 22, 2026 - - Latest News -
An architect of the first industry–Commonwealth medicines pact to lead CSL
October 21, 2026 - - Latest News -
Quarterly update shows Telix holds course for a US$1 billion milestone year
October 21, 2026 - - Latest News -
Chemist Warehouse keeps growing as Sigma sets its sights on oral GLP-1s
October 21, 2026 - - Latest News -
America's ever rising GLP-1 curve and how Australia is following
October 21, 2026 - - Latest News -
Patient groups across Asia-Pacific push for a say on medicine prices
October 21, 2026 - - Latest News
